“…While 13-valent conjugate pneumococcal vaccination (PCV13) is routinely recommended for adults aged ≥65 years, it has not been recommended for younger adults with diabetes. …”
Enlace del recurso
Enlace del recurso

“…Introduction of 10/13-valent childhood pneumococcal vaccines (2014) in Belgium has changed the overall serotype distribution, also possibly leading to a shift in PAgT performance. …”
Enlace del recurso
Enlace del recurso

“…Vaccination at ≥ 65 years was used in alignment with the influenza and pneumococcal vaccines recommended from 65 years. Japan-specific data inputs for the model were obtained from local data sources. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CONCLUSION: Despite recommendations of universal pneumococcal vaccination in older adults aged 65 years and above in the United States, the burden of pneumococcal disease remains high, particularly among those with chronic and immunocompromising conditions. …”
Enlace del recurso
Enlace del recurso

“…These findings support sustaining pneumococcal vaccination to reduce pneumonia-related mortality in children.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In another multivariable model, higher odds of willingness to receive vaccines were associated with kidney disease (OR = 3.3, 95% CI: 1.01 to 10.5), perceived risk of VPD (OR = 1.9, 95% CI: 1.02 to 3.3), previous influenza vaccination (OR = 3.4, 95% CI: 1.8 to 6.5), and previous pneumococcal vaccination (OR = 3.1, 95% CI: 1.3 to 7.7), but increasing age (OR = 0.93 per year, 95% CI: 0.91 to 0.97), working (OR = 0.40, 95% CI: 0.20 to 0.78), and fear of vaccine side effects (OR = 0.38, 95% CI: 0.21 to 0.68) were predictive of lower odds of willingness to receive vaccines. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Despite conjugate pneumococcal vaccines that have otherwise been successful in reducing invasive disease caused by vaccine serotypes, the incidence of pneumococcal meningitis remains relatively unchanged. …”
Enlace del recurso
Enlace del recurso

“…Study subjects were stratified by age (18–49, 50–64, and ≥65 years) and risk profile (“at-risk”, “high-risk”, and “healthy”) based on ACIP-identified indications for pneumococcal vaccination. Episodes of IPD were identified in each year of the study period, and rate ratios comparing IPD incidence in persons with at-risk and high-risk conditions, respectively, vs. healthy persons, were computed. …”
Enlace del recurso
Enlace del recurso

“…HCPs’ belief that vaccination prevents influenza infection (OR = 3.93, 95% CI = 1.97–7.82), their awareness of the Scientific Committee for Influenza and Pneumococcal Vaccination (SCIPV)‘s guidelines (OR = 2. 13, 95% CI = 1.16–3.90) and the presence of the standing orders regarding influenza vaccine (OR = 1.57, 95% CI = 1.01–3.21), were the predictors for receipt of influenza vaccine by HCPs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…There is currently no recommendation for adult pneumococcal vaccination with either pneumococcal polysaccharide vaccine or PCVs in Mongolia. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Evidence is mixed regarding the differences in immunogenicity and efficacy of the different pneumococcal vaccines. METHODS: In this systematic-review and network meta-analysis, we searched the Cochrane Library, Embase, Global Health, Medline, clinicaltrials.gov and trialsearch.who.int up to February 17, 2023 with no language restrictions. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Extensive efforts have been made toward improving effective strategies for pneumococcal vaccination, focusing on evaluating the potential of multivalent protein-based vaccines and overcoming the limitations of pneumococcal polysaccharide-based vaccines. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: The advent of enhanced conjugate pneumococcal vaccines for adults has created a need to assess the burden of pneumococcal disease in different populations to support recommendations for vaccination. …”
Enlace del recurso
Enlace del recurso

“…RESULTS: At the time of the 2002 survey, 94% of eligible children had received catch-up pneumococcal vaccination. 324 adults (538 examinations) and 218 children (350 examinations) were enrolled. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Strategies aimed at preventing pneumonia (i.e., influenza and pneumococcal vaccination) in high-risk populations need to be optimized. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In these countries, major reductions in child pneumonia mortality can be achieved only if the systemic challenges plaguing the health system (poor coverage of early infant testing for HIV, of antiretroviral drugs in pregnant women and young children, of co-trimoxazole prophylaxis, and of pneumococcal vaccination) can be overcome. FUNDING: WHO.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CONCLUSION: Seventy to eighty-five percent of adult IPD in the pre-PCV era were vaccine serotypes and 93% of cases had recognized risk factors (including HIV-infection) for pneumococcal vaccination. These data describe the epidemiology of IPD amongst HIV-infected and -uninfected adults during the pre-PCV era and provide a robust baseline to calculate the indirect effect of PCV in future studies.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A highly reactive surveillance system is thus necessary not only to monitor evolutions due to vaccine pressure and to verify the local serotypic appropriateness of new higher-valent pneumococcal vaccines, but also to recognise and prevent unexpected changes due to other internal or external factors. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Identified serotypes were grouped according to the available pneumococcal vaccines and further analyzed into pre-vaccination (2000–2009) and post-vaccination periods (2010–2017). …”
Enlace del recurso
Enlace del recurso

“…Being appropriate to treat was more likely with pneumococcal vaccinations PCV13 (35% vs. 15%, P < 0.0001) and/or PPSV23 (72% vs. 59%, P = 0.003). …”
Enlace del recurso
Enlace del recurso